Navigation Links
OncoSec Medical to Present at the HemOnc Today Melanoma and Cutaneous Malignancies Meeting in New York
Date:3/18/2013

ry, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in OncoSec Medical's filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward looking statements which speak only as of the date they are made. OncoSec Medical disclaims any obligation
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 Germany ... Summary GlobalData,s new report, "Germany Gynecological Devices ... on the Germany Gynecological Devices market. The report ... (in units) and average prices (in US dollars) ... Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal ...
(Date:9/17/2014)... , Sept. 17, 2014  Levi & Korsinsky, ... connection with possible claims of breaches of fiduciary duty ... To get more information, click here: http://zlk.9nl.com/alexza-pharmaceuticals-alxa ... If you own common stock in Alexza ... contact Eduard Korsinsky, Esq. either via email ...
(Date:9/17/2014)... 2014 Pomerantz LLP is investigating claims on ... or the "Company") (NASDAQ: PDLI).  Such investors are advised ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ... officers and/or directors have violated Sections 10(b) and 20(a) ... On September 17, 2014, the Company announced that ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2
... chemotherapy-soaked beads to choke off and kill cancerous ... research being presented at the 21st annual International ... a minimally invasive therapy that takes a two-pronged ... minimally invasive methods to deliver the beads (also ...
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced ... solution) has been accepted for review by the U.S. Food ... for Bepreve as an eye drop treatment for ocular itching ... review of ten months and has been given a user ...
Cached Medicine Technology:Chemoembolization Improving as Liver Cancer Treatment 2Chemoembolization Improving as Liver Cancer Treatment 3Chemoembolization Improving as Liver Cancer Treatment 4ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration 2ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration 3
(Date:9/18/2014)... (PRWEB) September 18, 2014 First ... freestanding emergency rooms in the United States, named Douglas ... new Missouri City-Lakes facility. , “We are pleased ... facility medical director of our new Missouri City-Lakes facility,” ... First Choice Emergency Room. , Dr. Harrison received ...
(Date:9/18/2014)... 18, 2014 9Lover.com, an internationally well-known ... recently launched a big promotion for its maternity wedding ... can buy discounted maternity wedding dresses on ... appreciation to all global consumers. The company’s development manager ... lot of ladies delighted. The current special offer will ...
(Date:9/17/2014)... 2014 A ball gown is the ... traditionally a full-skirted gown reaching the floor, made of ... well-known special occasion gown manufacturer and retailer, has delightedly ... gorgeous ball gowns are offered at discounted rates. , ... necklines. Such gowns are typically worn with a stole ...
(Date:9/17/2014)... The National Resident Matching Program has published ... analysis of the relationship between unique applicant characteristics and ... new edition is based on the 2014 Main Residency ... medical school senior students and all other applicants. , ... this new edition of Charting Outcomes in the Match,” ...
(Date:9/17/2014)... 2014 In its latest blog post, ... alcohol treatment program that gets clients off to a ... recovery they can believe in, is exploring the dangerous ... Americans who are afflicted with depression are also addicted ... CEO Per Wickstrom . “Unfortunately, these two very ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Douglas J. Harrison as Medical Director of Missouri City - Lakes, Texas Facility 2Health News:Discounted Maternity Wedding Dresses For 2014 Introduced By 9Lover.com 2Health News:Fecbek.com: Ladies Can Be Elegant Enough to Draw Everyone’s Attention by Wearing Trendy Ball Gowns 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 3Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 2Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 3
... ... as Vice President of Sales. Separately, Kardea has announced that it has extended ... ... LLC announced today that Robert Lukasik has joined the company as Vice President of Sales. ...
... , WASHINGTON , Feb. 15 ... U.S. Census Bureau: , (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) , ... , Profile America — Monday, February 15th . ... became the first American to win the women,s World Figure Skating ...
... a hospital is in orthopedic surgical care, the better the ... replacement surgery, University of Iowa researchers report in a new ... were fewer serious post-surgical complications such as blood clots, infections ... The findings, which were published online Feb. 11 by the ...
... , TEMPE, Ariz. , Feb. 14 Local ... efforts to benefit breast cancer research and the Susan G. Komen ... beginning at 8:30am . , "Change Your ... kid zone event hosted by ASU Karsten Golf Course, 1125 East ...
... work, researchers say , SUNDAY, Feb. 14 (HealthDay News) -- ... here,s good news. , Office romances don,t bother fellow workers ... finds. , "Most people believe romantic relationships [at work] are ... colleagues or have an impact on the overall work environment," ...
... ... affordable 100% natural latex mattress or 100% natural latex topper. Mattress covers are made ... mattress, free from chemical fire-retardants. , ... (PRWEB) February 14, 2010 -- Foamsource has added the Natural Slumber ...
Cached Medicine News:Health News:Kardea Nutrition Adds V.P. Sales, Extends Distribution Network 2Health News:U.S. Census Bureau Daily Feature for Feb. 15 2Health News:Medicare data reveals differences in orthopedic surgical outcomes 2Health News:Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates' Fight Against Breast Cancer 2Health News:Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates' Fight Against Breast Cancer 3Health News:Office Romance OK With Most Folks 2Health News:Foamsource Introduces Natural Slumber 100% Natural Latex Mattresses & Toppers with Free Shipping 2Health News:Foamsource Introduces Natural Slumber 100% Natural Latex Mattresses & Toppers with Free Shipping 3
5 mm concave jaws, cross action....
... inserter is the first of its kind. ... through a minimal incision. The special direct-acting ... bag with complete control and predictability. The ... easy around-the-clock, and the instrument has a ...
... SI-30 and SI-40 foldable lenses through incisions as ... clear corneal and corneal scleral tunnels. The inserter ... rounded blades for a secure grasp of a ... a .15 millimeter notch which may be used ...
KR-8000 Supra is capable of obtaining perfectly accurate keratometry and/or refraction measurements through pupils as narrow as 2.0 mm....
Medicine Products: